Skip to content
HowShorted

ADIAL PHARMACEUTICALS, INC. short interest in 2023

In 2023, ADIAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 0.54% of shares outstanding on 13 Jan 2023 to 2.74% on 29 Dec 2023, a change of +2.20 percentage points. The year's high was 5.30% on 31 Aug 2023 and its low 0.50% on 31 Jan 2023, averaging 2.33% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.55 days on 15 Nov 2023. Full history: ADIAL PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ADIAL PHARMACEUTICALS, INC. in 2023

2023 in figures

Start of year
0.54% (13 Jan 2023)
End of year
2.74% (29 Dec 2023)
Change
+2.20 pp
High
5.30% (31 Aug 2023)
Low
0.50% (31 Jan 2023)
Average
2.33%
Highest days to cover
4.55 (15 Nov 2023)
SEC filings marked
8

Every report in 2023

ADIAL PHARMACEUTICALS, INC. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20230.54%1.00
31 Jan 20230.50%1.00
15 Feb 20231.03%1.00
28 Feb 20231.42%1.83
15 Mar 20232.02%1.00
31 Mar 20231.16%2.3710-K filed, results (8-K)
14 Apr 20231.02%1.34
28 Apr 20231.46%1.00
15 May 20231.14%2.6510-Q filed, results (8-K)
31 Aug 20235.30%1.0210-Q filed, results (8-K)
15 Sep 20232.79%1.00
29 Sep 20234.17%1.00
13 Oct 20232.29%2.46
31 Oct 20234.42%1.56
15 Nov 20234.35%4.5510-Q filed, results (8-K)
30 Nov 20233.38%1.00
15 Dec 20232.12%1.00
29 Dec 20232.74%1.00

See also: ADIAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.